![]() SignatureCare Emergency Center has been approved to administer Eli Lilly’s Bamlanivimab (LY-CoV555) and Etesevimab COVID-19 treatment to patients through its network of 24-hour emergency centers located in Texas.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |